Application
17750855 · CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF
Filed 2022-05-23 · Granted · Patent 11608369 (2023-03-21) The official file ↗The patent and its PDF ↗ · Art unit 1633 · Examiner Scott Long Easy · CPC A61P 35/00 · Cellular Biomedicine Group, Inc. · Leason Ellis LLP
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
2.3 mo
to disposition 9.9 mo
Statutes raised
DP
1 actions read